116 related articles for article (PubMed ID: 33592912)
1. ETS1 polymorphism rs73013527 in relation to serum RANKL levels among patients with RA.
Yang B; Luo L; Chen L; Niu Q; Zhang J; Xu H; Wu Y; Huang Z
Medicine (Baltimore); 2021 Feb; 100(5):e24562. PubMed ID: 33592912
[TBL] [Abstract][Full Text] [Related]
2. Association of E26 Transformation Specific Sequence 1 Variants with Rheumatoid Arthritis in Chinese Han Population.
Chen L; Huang Z; Yang B; Cai B; Su Z; Wang L
PLoS One; 2015; 10(8):e0134875. PubMed ID: 26241881
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
[TBL] [Abstract][Full Text] [Related]
4. E26 transformation-specific-1 (ETS1) and WDFY family member 4 (WDFY4) polymorphisms in Chinese patients with rheumatoid arthritis.
Zhang Y; Bo L; Zhang H; Zhuang C; Liu R
Int J Mol Sci; 2014 Feb; 15(2):2712-21. PubMed ID: 24549174
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.
Boman A; Kokkonen H; Ärlestig L; Berglin E; Rantapää-Dahlqvist S
Clin Rheumatol; 2017 May; 36(5):1005-1012. PubMed ID: 28190118
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment.
Wielińska J; Kolossa K; Świerkot J; Dratwa M; Iwaszko M; Bugaj B; Wysoczańska B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz); 2020 Aug; 68(4):24. PubMed ID: 32815001
[TBL] [Abstract][Full Text] [Related]
7. Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis.
Ellabban AS; Kamel SR; Ahmed SS; Osman AM
Rheumatol Int; 2012 Jun; 32(6):1589-96. PubMed ID: 21328055
[TBL] [Abstract][Full Text] [Related]
8. Altered sequence of the ETS1 transcription factor may predispose to rheumatoid arthritis susceptibility.
Chatzikyriakidou A; Voulgari PV; Georgiou I; Drosos AA
Scand J Rheumatol; 2013; 42(1):11-4. PubMed ID: 23101665
[TBL] [Abstract][Full Text] [Related]
9. A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.
Tan W; Wu H; Zhao J; Derber LA; Lee DM; Shadick NA; Conn DL; Smith EA; Gersuk VH; Nepom GT; Moreland LW; Furst DE; Thompson SD; Jonas BL; Holers VM; Glass DN; Chen PP; Bridges SL; Weinblatt ME; Paulus HE; Tsao BP
Arthritis Rheum; 2010 Oct; 62(10):2864-75. PubMed ID: 20533289
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
Xu S; Wang Y; Lu J; Xu J
Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
[TBL] [Abstract][Full Text] [Related]
12. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
13. [Increased receptor activator of nuclear factor kappa B ligand expressed on B10 cells in rheumatoid arthritis].
Liu HJ; Guo XF; Hu FL; Yan CP; Cui XJ; Yan XL; Li ZG; Jia Y; Song SL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):968-974. PubMed ID: 30562766
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of RANKL/OPG, dickkopf-1 and bone marrow edema in rheumatoid arthritis with the complaint of knee pain].
Li M; Wu XH; Yin G; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):276-9. PubMed ID: 25924445
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients.
Mohamed RH; Mohamed RH; El-Shahawy EE
Genet Test Mol Biomarkers; 2016 May; 20(5):249-54. PubMed ID: 26914636
[TBL] [Abstract][Full Text] [Related]
16. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.
Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146
[TBL] [Abstract][Full Text] [Related]
17. MSRA polymorphism is associated with the risk of rheumatoid arthritis in a Chinese population.
Zhang Y; Zhang H; Zhuang C; Liu R; Wei J
Scand J Rheumatol; 2013; 42(2):91-6. PubMed ID: 23244167
[TBL] [Abstract][Full Text] [Related]
18. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.
Wu H; Khanna D; Park G; Gersuk V; Nepom GT; Wong WK; Paulus HE; Tsao BP
Arthritis Rheum; 2004 Oct; 50(10):3093-103. PubMed ID: 15476205
[TBL] [Abstract][Full Text] [Related]
19. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.
Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kamatani N; Kotake S
Clin Rheumatol; 2007 Dec; 26(12):2137-2141. PubMed ID: 17876645
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
